HTA184 Investigating How Orphan Drug Manufacturers Can Optimize Clinical Trial Design so Patients across Geographies Can Access Life-Saving Innovations

Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.1642
https://www.valueinhealthjournal.com/article/S1098-3015(22)03847-5/fulltext
Title : HTA184 Investigating How Orphan Drug Manufacturers Can Optimize Clinical Trial Design so Patients across Geographies Can Access Life-Saving Innovations
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)03847-5&doi=10.1016/j.jval.2022.09.1642
First page :
Section Title :
Open access? : No
Section Order : 11195
Categories :
Tags :
Regions :
ViH Article Tags :